Regulatory Framework for Bioactives in India and Global Markets

Building Trust, Safety, and Growth

The global food and wellness industry is experiencing a major shift toward preventive healthcare and functional nutrition. Consumers are increasingly choosing products that provide health benefits beyond basic nutrition, such as immunity support, better digestion, sports recovery, heart health, cognitive well-being, and overall wellness management.

This changing consumer preference has significantly increased the demand for bioactive ingredients in the food processing, nutraceutical, pharmaceutical, and wellness industries.

What Are Bioactives?

Bioactives are natural compounds found in plants, fruits, vegetables, herbs, grains, marine sources, and microorganisms. These compounds provide physiological or functional health benefits beyond basic nutrition and help support better health outcomes.

Common examples include:

• Curcumin from turmeric
• Probiotics in fermented foods
• Omega-3 Fatty Acids from fish oil
• Polyphenols from tea and berries
• Plant Sterols used in heart-health products

Today, bioactives are increasingly incorporated into probiotic beverages, fortified foods, nutrition supplements, wellness gummies, sports nutrition products, and preventive healthcare formulations.

Regulations for Bioactives in India

In India, the bioactive, nutraceutical, and functional food industry is primarily regulated by the Food Safety and Standards Authority of India (FSSAI). Depending on product claims and composition, products may also fall under the Central Drugs Standard Control Organization (CDSCO) or the Ministry of AYUSH.

Why Regulation Matters

Strong regulatory systems help:

• Ensure consumer safety
• Prevent misleading health claims
• Maintain ingredient quality standards
• Improve transparency and traceability
• Support smoother domestic and international approvals

For businesses, compliance strengthens brand credibility and long-term market sustainability.

FSSAI Regulations, 2016

The Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016 provide the primary framework for this sector.

The regulations define:

• Ingredient approval processes
• Permitted vitamins, minerals, amino acids, and probiotic strains
• Botanical ingredients and extracts
• Usage limits and labelling norms
• Health claim requirements
• Licensing and compliance procedures

Product Categories Under FSSAI

FSSAI classifies products into several categories:

• Health Supplements
• Nutraceuticals
• Functional Foods
• Foods for Special Dietary Use (FSDU)
• Foods for Special Medical Purpose (FSMP)
• Novel Foods

For example, a probiotic drink may fall under Functional Foods, while Omega-3 capsules may be classified as Nutraceuticals.

Ingredient Approval Pathways

Track A – Standardized Pathway

If an ingredient is listed in the official FSSAI schedules, it is considered pre-approved. Manufacturers must:

• Follow permitted usage limits
• Maintain purity standards
• Complete FoSCoS licensing requirements

Track B – Non-Specified Ingredient Pathway

Ingredients not listed in the schedules are classified as Non-Specified Food Ingredients or Novel Foods and require prior approval.

Manufacturers must provide:

• History of Safe Use (HoSU)
• Characterization and purity data
• Toxicological safety studies

Scientific review timelines typically range from 90 to 120 days.

Labelling and Claims Regulations

Under the FSS (Advertising and Claims) Regulations, 2018, medicinal and disease-treatment claims are prohibited for food and supplement products.

Permitted Claims

Examples include:

• Supports immunity
• Helps maintain heart health
• Supports digestive wellness

Prohibited Claims

Examples include:

• Cures diabetes
• Eliminates cancer
• Permanent weight loss solution

Mandatory labelling requirements include category declaration, ingredient information, advisory statements, nutritional details, and appropriate vegetarian or non-vegetarian logos.

The Food–Drug Interface: CDSCO

A common challenge in India is determining whether a product falls under food regulations or pharmaceutical regulations.

Products may come under CDSCO if they:

• Claim to treat or cure diseases
• Contain highly potent pharmacologically active substances
• Exceed permitted dosage thresholds for nutrients

In such cases, the product may be regulated under the Drugs and Cosmetics Act, 1940.

AYUSH and Traditional Herbal Bioactives

India's traditional medicine systems create a separate regulatory pathway for herbal products.

If a product is developed using ingredients and methods described in classical Ayurvedic texts, it may be regulated under the Ministry of AYUSH.

Such products can use traditional Ayurvedic positioning and claims within the applicable regulatory framework.

Global Regulatory Framework for Bioactives

As the bioactive industry expands internationally, understanding global regulations becomes essential for market access and exports.

United States

• Regulatory Authority: FDA
• Main Regulation: DSHEA, 1994
• Product Category: Dietary Supplements
• Focus Areas: Safety, GMP, labelling, adverse event monitoring

European Union

• Regulatory Authority: EFSA
• Focus Areas: Scientific validation, safety, traceability
• Health Claims: Only EFSA-approved claims permitted

Japan

• Regulatory Authority: Consumer Affairs Agency
• Systems: FOSHU and FFC
• Focus Areas: Preventive healthcare and scientifically validated claims

China

• Regulatory Authority: SAMR
• Product Category: Health Foods and Nutraceuticals
• Focus Areas: Registration, traceability, and import control

Australia

• Regulatory Authority: TGA
• Product Category: Complementary Medicines
• Focus Areas: GMP compliance and manufacturing quality

Canada

• Regulatory Authority: Health Canada
• Product Category: Natural Health Products
• Focus Areas: Product quality, safety, and licensing

United Kingdom

• Regulatory Authority: Food Standards Agency (FSA)
• Focus Areas: Consumer safety and regulatory compliance

ASEAN Countries

• Framework: ASEAN Harmonized Guidelines for Health Supplements
• Focus Areas: Regional trade facilitation and safety harmonization

Key Takeaways

Successfully launching bioactive products requires regulatory planning from the earliest stages of product development.

Businesses should:

• Verify ingredient approval status
• Follow permitted nutrient limits
• Use compliant structure-function claims
• Maintain scientific documentation
• Implement robust quality assurance systems

It is equally important to differentiate between nutraceuticals, health supplements, pharmaceutical products, and AYUSH formulations.

Conclusion

Although regulatory systems differ across countries, the common objectives remain consumer safety, product quality, scientific validation, and responsible health claims.

Companies that focus on compliance, transparency, evidence-based product development, and quality assurance will be better positioned to achieve smoother approvals, stronger consumer trust, export growth, and long-term success in the rapidly expanding bioactive market.